Ken Keller, CEO of Daiichi Sankyo’s U.S. business, reflects on the challenges, triumphs and lessons learned as he transforms a long-established cardiovascular company into a global leader in oncology and drives a vision for a new future for cancer care.
A big bet, a bold step
Leave a comment
